Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

GLP-1s | Image credit: Patrick Bay Damstead - stock.adobe.com
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes

August 6th 2025

Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA).

Mina Massaro-Giordano, MD
Patients With Dry Eye Have More Treatment Options Than Ever Before: A Q&A With Mina Massaro-Giordano, MD

July 18th 2025

Man using eye drops | Image credit: 9nong - stock.adobe.com
Dry Eye Awareness Month Highlights Condition Affecting Millions

July 8th 2025

Man applying eye drops | Image credit: StockImageFactory
Education Surrounding Dry Eye a Persistent Barrier in Treatment

July 8th 2025

Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease
Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease

July 7th 2025

Continuing Medical Education
View All
August 12th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 12th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
August 12th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 12th 2025

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry
August 12th 2025

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry
August 12th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry
August 12th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

More News

Hasenin Al-khersan, MD
February 28th 2025

Symptoms of AMD Not Always Obvious to Patients

Julia Bonavitacola Hasenin Al-khersan, MD
The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to Hasenin Al-khersan, MD.
Paul Hahn, MD, PhD
February 26th 2025

Future Treatments for AMD Could Mitigate Burden on Patients

Julia Bonavitacola
Reducing the number of intravitreal injections to treat age-related macular degeneration (AMD) is a top priority in current treatment research, says Paul Hahn, MD, PhD.
Eye drops | Image credit: lllonajalll - stock.adobe.com
Published: February 25th 2025 | Updated: February 25th 2025

Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane

Julia Bonavitacola
Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.
Hasenin Al-khersan, MD
February 21st 2025

Knowing Risk Factors for AMD Can Lead to Best Prognosis

Julia Bonavitacola
Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help to maintain vision, says Hasenin Al-khersan, MD.
Paul Hahn, MD, PhD
February 19th 2025

Distortion, Central Blurriness Among Major Symptoms of AMD

Julia Bonavitacola
Paul Hahn, MD, PhD, discussed signs and symptoms of age-related macular degeneration (AMD) during AMD Awareness Month.
Woman with glaucoma | Image credit: Africa Studio - stock.adobe.com
February 11th 2025

Enhanced Monofocal Lenses May Provide Alternative in Glaucoma Treatment

Julia Bonavitacola
Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal intraocular lenses.
Older woman having problems with vision | Image credit: Home-stock - stock.adobe.com
February 7th 2025

5 Things to Know During AMD Awareness Month

Julia Bonavitacola
Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.
AMD Test | Image credit: Andrey Popov - stock.adobe.com
February 4th 2025

Brolucizumab Effective in Patients With Wet AMD, Regardless of Past Treatment

Julia Bonavitacola
Wet age-related macular degeneration (AMD) can be managed using brolucizumab due to its efficacy.
FDA approved. | Image Credit: Pawel - stock.adobe.com
Published: February 4th 2025 | Updated: February 4th 2025

FDA Approves Ranibizumab Implant in Treatment of DME

Julia Bonavitacola
The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year for the treatment of diabetic macular edema (DME).
Jonathan Eisengart, MD
January 30th 2025

Consistent Screening Important for Addressing Glaucoma

Julia Bonavitacola
The asymptomatic nature of glaucoma makes it imperative to get consistent screening to catch the condition early.
Semaglutide | Image credit: Starmarpro - stock.adobe.com
January 30th 2025

Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications

Julia Bonavitacola
A rapid correction of hyperglycemia could be associated with ophthalmic complications based on several cases.
Macular degeneration | Image credit: RFBSIP - stock.adobe.com
January 30th 2025

Resveratrol Oral Supplement Associated With Lower Rates of Intravitreal Aflibercept Injections

Julia Bonavitacola
Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the resveratrol oral supplement.
Jonathan Eisengart, MD
January 27th 2025

Research on Treatments for Glaucoma Shifting to Focus on Drug Delivery, Extended Duration

Julia Bonavitacola
Although most of the innovation in treatment has come in the past decade, new treatments for glaucoma are still being tested, albeit at a slower pace.
Visually impaired man at table | Image credit: LIGHTFIELD STUDIOS – stock.adobe.com
January 22nd 2025

Making the Emergency Department More Accessible for Visually Impaired Patients

Hayden E. Klein
Patients with visual impairments face major physical and financial barriers when seeking emergency care.
Dry eye | Image credit: lenblr - stock.adobe.com
January 22nd 2025

Decreased Levels of CGRP, SP Associated With Dry Eye Disease

Julia Bonavitacola
Calcitonin gene-related peptide (CGRP) and substance P (SP) had correlations with symptoms and signs of dry eye disease.
Jonathan Eisengart
January 20th 2025

Medications, Laser Can Be Used to Treat Glaucoma

Julia Bonavitacola
Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD.
Visual acuity | Image credit: Miroslav110 - stock.adobe.com
January 15th 2025

Visual Acuity Enhanced in Patients With DME, RVO With Foveal Bulge

Julia Bonavitacola
Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) or retinal vein occlusion (RVO).
Jonathan Eisengart
January 13th 2025

Glaucoma Can Go Years Undetected Due to Few Noticeable Symptoms

Julia Bonavitacola
Glaucoma can cause damage to the optic nerve if left untreated, making frequent eye appointments vital for catching it quickly.
Woman with glaucoma | Image credit: Africa Studio - stock.adobe.com
January 8th 2025

Thinning in GCIPL, RNFL Different in Glaucoma Subtypes

Julia Bonavitacola
The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was different in people with primary open angle glaucoma and pseudoexfoliation glaucoma.
Woman taking eye exam | Image credit: Rabizo Anatolii - stock.adobe.com
January 3rd 2025

Response Times to Visual Stimulus Slower in Patients With Glaucoma

Julia Bonavitacola
When compared with auditory stimulus, patients with glaucoma had slower response times to visual stimulus.
Test for AMD | Image credit: RFBSIP - stock.adobe.com
December 23rd 2024

Intravitreal Faricimab Associated With Increased Treatment Interval, Decreased CST

Julia Bonavitacola
Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated for neovascular age-related macular degeneration, best corrected visual acuity showed no sign of improvement.
Top 5 Ophthalmology Articles of 2024
December 23rd 2024

Top 5 Most-Read Ophthalmology Articles of 2024

Julia Bonavitacola
Articles covering FDA approvals, dry eye disease, and how eye diseases may be linked to falls were among the top 5 most-read articles of 2024.
Retinopathy | Image credit: NanSan - stock.adobe.com
December 18th 2024

Hyperglycemia Biggest Risk Factor in Retinopathy

Julia Bonavitacola
Obesity, overweight, and hypertension could also affect the risk of retinopathy if not managed in patients.
Contact lens | Image credit: Kitreel - stock.adobe.com
December 11th 2024

Visual Acuity, OSDI Improved With Use of Hydrogen Peroxide in Dry Eye Caused by Contacts

Julia Bonavitacola
Patients with dry eye associated with contact lenses had significant improvement in visual acuity and their Ocular Surface Disease Index (OSDI) score after a month of using hydrogen peroxide.
Doctor displaying retina | Image credit: Phanphen - stock.adobe.com
December 3rd 2024

Pregnancy Could Worsen Progression of Retinitis Pigmentosa

Julia Bonavitacola
Women who had children had a higher risk of reaching a visual acuity below 6/24 compared with those who did not have children.
Close up of a woman's eye | Image credit: Artem Markin - stock.adobe.com
November 29th 2024

5 Things About Diabetic Eye Disease

Laura Joszt, MA
November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a look at recent research related to diabetic eye diseases.
Amblyopia | Image credit: sasha1806 - stock.adobe.com
November 27th 2024

Visual Acuity Improvements Found After Rehabilitation With Digital Video Games

Julia Bonavitacola
Patients with amblyopia had a statistically significant improvement in their visual acuity after binocular rehabilitation through digital video games.
Glaucoma | Image credit: Alessandro Grandini - stock.adobe.com
November 21st 2024

Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment

Julia Bonavitacola
Glaucoma risk can be managed more effectively with the ability to use polygenic risk scores to identify individuals who can benefit from more intense treatment.
Eye | Image credit: Liudmila Dutko - stock.adobe.com
November 13th 2024

Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101

David Hutton
Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber congenital amaurosis (LCA1). Nippon Shinyaku will commercialize ATSN-101 in the US and Japan, while Atsena retains global rights outside these territories.
Glaucoma | Image credit: Yakobchuk Olena - stock.adobe.com
November 12th 2024

Polygenic Risk Score Important to Track POAG Onset

Julia Bonavitacola
Polygenic risk score was valuable in enhancing risk prediction models for primary open-angle glaucoma (POAG.
<12345678
...
19>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo